摘要
原发性骨质疏松症是以骨量减少、骨质微观结构退化为特征的一种全身性疾病。其主要并发症是各种脆性骨折,也是引起病残和死亡的主要原因。骨质疏松症已经成为严峻的公共卫生及社会问题。笔者通过查阅国内外有关治疗骨质疏松症药物的文献报道,对近几年来抗骨质疏松症药物的研究进展进行综述,为临床防治骨质疏松症的医务工作人员做一有益参考。
One of the characters of primary osteoporosis is bone fragility due to low bone mass and regression of the internal bone structure, with alterations of its microarchitecture. The main complication of osteoporosis is various fragility fractures, which led to disablement and death. Osteoporesis has become a seriously social and public health problem in the world. The present summary consulting recent literatures of osteoporosis drugs aims to providing a reference to clinical prevention and treatment of osteoporosis.
出处
《中国骨质疏松杂志》
CAS
CSCD
2007年第6期436-439,405,共5页
Chinese Journal of Osteoporosis
关键词
骨质疏松
药物
骨密度
Osteoporosis
Drugs
Bone Mass Density（BMD）
